Scheme

ICICI Prudential Nifty Healthcare ETF

Holds 20 companies worth ₹231 Cr in Sept 2026.

Fund house
ICICIThe fund house that runs this scheme.
AUM
₹231 CrICICI Prudential Nifty Healthcare ETF's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 2.3% on Aug 2026, ₹237 Cr.
Largest holding
Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 17.0% of this scheme's NAV.
Fund manager
Nishit PatelRuns its co-manager part since 18 May 2021, as the fund house dates it. With Ashwini Bharucha (co-manager), Venus Ahuja (co-manager).

Holdings^{(May 2021 – Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	20 companies ·	₹ Cr
	Sun Pharmaceutical Ind Ltd	39.3
	Divi s Laboratories Limited	24.2
	Apollo Hospitals Enterprise Limited	17.2
	Laurus Labs Limited	15.8
	Cipla	15.5
	Dr Reddy s Laboratories Limited	15.4
	Torrent Pharmaceuticals Limited	14.5
	Max Healthcare Institute Limited	14.2
	Lupin	10.1
	Aurobindo Pharma	9.5
	Fortis Healthcare Limited	8.2
	Glenmark Pharmaceuticals	7.2
	Alkem Laboratories Limited	6.4
	Cadila Healthcare	5.9
	Mankind Pharma Limited	5.8
	IPCA Laboratories Limited	5.5
	Biocon	5.3
	Gland Pharma Limited	4.7
	Krishna Institute of Medical Science Ltd	4.1
	Abbott India Limited	2.9

Fig. 1.Market value of each ticked company in ICICI Prudential Nifty Healthcare ETF, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

Sun Pharmaceutical Ind Ltd	Equity	Pharmaceuticals & Biotechnology	2.17L	39.3	17.00
Divi s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	26K	24.2	10.44
Apollo Hospitals Enterprise Limited	Equity	Healthcare Services	21K	17.2	7.43
Laurus Labs Limited	Equity	Pharmaceuticals & Biotechnology	79.7K	15.8	6.82
Cipla	Equity	Pharmaceuticals & Biotechnology	1.15L	15.5	6.69
Dr Reddy s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	1.25L	15.4	6.65
Torrent Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	30.1K	14.5	6.24
Max Healthcare Institute Limited	Equity	Healthcare Services	1.52L	14.2	6.12
Lupin	Equity	Pharmaceuticals & Biotechnology	49.7K	10.1	4.36
Aurobindo Pharma	Equity	Pharmaceuticals & Biotechnology	56.5K	9.5	4.08
Fortis Healthcare Limited	Equity	Healthcare Services	1.07L	8.2	3.55
Glenmark Pharmaceuticals	Equity	Pharmaceuticals & Biotechnology	30.8K	7.2	3.11
Alkem Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	12.3K	6.4	2.75
Cadila Healthcare	Equity	Pharmaceuticals & Biotechnology	50.7K	5.9	2.54
Mankind Pharma Limited	Equity	Pharmaceuticals & Biotechnology	23.2K	5.8	2.51
IPCA Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	28.4K	5.5	2.37
Biocon	Equity	Pharmaceuticals & Biotechnology	1.43L	5.3	2.28
Gland Pharma Limited	Equity	Pharmaceuticals & Biotechnology	16.3K	4.7	2.04
Krishna Institute of Medical Science Ltd	Equity	Healthcare Services	54.6K	4.1	1.76
Abbott India Limited	Equity	Pharmaceuticals & Biotechnology	1.07K	2.9	1.25

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.